KRISHI
ICAR RESEARCH DATA REPOSITORY FOR KNOWLEDGE MANAGEMENT
(An Institutional Publication and Data Inventory Repository)
"Not Available": Please do not remove the default option "Not Available" for the fields where metadata information is not available
"1001-01-01": Date not available or not applicable for filling metadata infromation
"1001-01-01": Date not available or not applicable for filling metadata infromation
Please use this identifier to cite or link to this item:
http://krishi.icar.gov.in/jspui/handle/123456789/33710
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeevan K | en_US |
dc.contributor.author | Suguna Rao | en_US |
dc.contributor.author | Satyanarayana ML | en_US |
dc.contributor.author | Byregowda SM | en_US |
dc.contributor.author | Leena G | en_US |
dc.contributor.author | Krishnamoorthy P | en_US |
dc.date.accessioned | 2020-03-10T08:45:00Z | - |
dc.date.available | 2020-03-10T08:45:00Z | - |
dc.date.issued | 2020-02-29 | - |
dc.identifier.citation | Not Available | en_US |
dc.identifier.issn | 2349-8528 | - |
dc.identifier.uri | http://krishi.icar.gov.in/jspui/handle/123456789/33710 | - |
dc.description | Not Available | en_US |
dc.description.abstract | To investigate the effects of zinc oxide nanoparticles (ZnO NPs) against hepatocarcinogenesis, the present study was conducted. To induce hepatocarcinogenesis rats with Diethylnitrosamine (DEN) at 100 mg/kg body weight intraperitoneally on Day 1 followed by 0.01 % DEN in drinking water ad libitum for 60 days. Zinc oxide nanoparticles as aqueous suspension was gavaged orally at a dose rate of 25 mg/kg body weight for 15 days prior to DEN treatment in ZnO NPs pre-treatment group and concurrently with DEN for 60 days in ZnO NPs concurrent treatment group. DEN induced severe hepatic damage and formation of preneoplastic altered hepatic foci by 30th day and severe fibrotic tissue proliferation with development of hepatic adenoma and carcinoma by 60th day. In pre-treatment and concurrent treatment groups, ZnO NPs reduced the extent of hepatic damage, prevented the formation of altered hepatic foci by 30th day and drastically reduced the extent of fibrotic tissue proliferation by 60th day which were determined through routine histopathology of hepatic tissue and special staining techniques alongside gross observation of liver. | en_US |
dc.description.sponsorship | Not Available | en_US |
dc.language.iso | English | en_US |
dc.publisher | International Journal of Chemical Studies | en_US |
dc.relation.ispartofseries | Not Available; | - |
dc.subject | Hepatocarcinogenesis | en_US |
dc.subject | ZnO NPs | en_US |
dc.subject | DEN | en_US |
dc.subject | altered hepatic foci | en_US |
dc.subject | Fibrosis | en_US |
dc.title | Anti-preneoplastic and anti-fibrogenetic effect of zinc oxide nanoparticles (ZnO NPs) against experimental hepatocarcinogenesis | en_US |
dc.title.alternative | Not Available | en_US |
dc.type | Research Paper | en_US |
dc.publication.projectcode | Not Available | en_US |
dc.publication.journalname | International Journal of Chemical Studies | en_US |
dc.publication.volumeno | 8(1) | en_US |
dc.publication.pagenumber | 2689-2693 | en_US |
dc.publication.divisionUnit | Not Available | en_US |
dc.publication.sourceUrl | http://www.chemijournal.com/archives/2020/vol8issue1/PartAO/8-1-356-992.pdf | en_US |
dc.publication.authorAffiliation | Veterinary College, Hebbal, Bengaluru | en_US |
dc.publication.authorAffiliation | ICAR::National Institute of Veterinary Epidemiology and Disease Informatics | en_US |
dc.ICARdataUseLicence | http://krishi.icar.gov.in/PDF/ICAR_Data_Use_Licence.pdf | en_US |
Appears in Collections: | AS-NIVEDI-Publication |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
8-1-356-992.pdf | 1.24 MB | Adobe PDF | View/Open |
Items in KRISHI are protected by copyright, with all rights reserved, unless otherwise indicated.